IGF-1 LR3 stack pairing — what the research literature has examined

Overview of which research peptides IGF-1 LR3 has been studied alongside in published preclinical research, and the rationale for those pairings in mechanism-level investigations.

IGF-1 LR3 in multi-peptide research

Preclinical research involving IGF-1 LR3 sometimes investigates it alongside other peptides — either to probe overlapping signalling pathways or to characterise additive versus synergistic effects in vitro. This page summarises the pairings that appear in the published literature at a citation level. It is not a recommendation, not a human-dosing protocol, and not a therapeutic stack.

A synthetic modified analogue of human IGF-1 with extended half-life, studied in cell-proliferation, myocyte-pathway, and tissue-research literature.

Pairings that appear in preclinical studies

Growth-hormone-axis peptides (e.g. CJC-1295 No DAC, Ipamorelin, GHRP-2) appear together in published preclinical research investigating GHRH/GHS-R co-signalling. Researchers studying IGF-1 LR3 sometimes include such peer compounds as comparators within mechanistic pathway studies.

Peptify supplies several of these compounds individually and, where the pairing rationale is well-established, in pre-blended research vials with a single Certificate of Analysis covering the combined formulation. Each constituent's identity and purity is HPLC-verified by Janoshik Analytical.

Pre-blended research vials at Peptify

Peptify currently offers four pre-blended multi-peptide research vials, each with a single Janoshik Certificate of Analysis confirming 99%+ HPLC purity for every constituent:

  • GLOW Blend 70mg — GHK-Cu (50mg) + TB-500 (10mg) + BPC-157 (10mg)
  • KLOW Blend 80mg — KPV + GHK-Cu + TB-500 + BPC-157
  • BPC-157 + TB-500 Recovery Blend 20mg
  • Selank + Semax Cognition Blend 20mg

A pre-blend supplies the combination as one lyophilised powder, one reconstitution, one COA — useful for researchers running fixed-ratio multi-peptide protocols where the ratio itself is part of the experimental design.

This content is provided for research and laboratory reference only. All Peptify
products are sold strictly for in-vitro research and are not intended for human or
animal consumption. Consult the Peptify compliance page for full regulatory details.

Buy IGF-1 LR3 for research

99%+ HPLC-verified IGF-1 LR3 in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.

Frequently asked questions

What is IGF-1 LR3?

IGF-1 LR3 is a modified version of IGF-1 with a 13-amino acid extension that prevents binding to IGF-binding proteins, resulting in enhanced bioactivity and a longer half-life.

What is IGF-1 LR3 researched for?

Published preclinical research has examined IGF-1 LR3 in cell-proliferation, myocyte-pathway, and PI3K/Akt signalling studies. The extended half-life makes it useful in protocols requiring sustained in-vitro receptor engagement.

What purity does Peptify supply?

Peptify IGF-1 LR3 is 99%+ HPLC-verified, with a batch-specific Janoshik Analytical Certificate of Analysis downloadable from the product page.